why choose us

First received: July 29, 2022

Clinical Trial: Study to Assess SLN124 in Patients With Polycythemia Vera

Study Status: Completed

Recruit Status: RECRUITING

Condition: Polycythemia Vera

Study Type: INTERVENTIONAL


Official Title: Phase 1/2 Study With an Open-label Dose Escalation Phase Followed by a Randomized, Double-blind Phase of SLN124 in Patients With Polycythemia Vera

Brief Summary: This is a Phase 1/2, multicenter study with an open-label dose escalation followed by a randomized placebo controlled and double-blind phase of SLN124 in adult patients with Polycythemia Vera (PV) to assess the safety, tolerability, efficacy, pharmacokinetic (PK), and Pharmacodynamic (PD) response of SLN124.

Read more